Get started
Author

Sarah J. Schep

Observed names: S. J. Schep, S.J. Schep, Schep, Sarah Judith
ORCID: 0000-0003-0021-356X
Observed ORCID: 0000-0003-0021-356X
OpenAlex ID: A5028383231
Review of immune tolerance induction in hemophilia A
2018 · S.J. Schep, R.E.G. Schutgens, et al. · Blood Reviews · 76
Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study
2020 · Sarah J. Schep, Wobke E. M. van Dijk, et al. · American Journal of Hematology · 59
PDF
Health-related quality of life in children with newly diagnosed immune thrombocytopenia
2014 · K. M. J. Heitink-Polle, L. Haverman, et al. · Haematologica · 50
PDF
An update on the ‘danger theory’ in inhibitor development in hemophilia A
2019 · Sarah J. Schep, Marianne Boes, et al. · Expert Review of Hematology · 29
PDF
Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A
2021 · Sarah J. Schep, Roger E. G. Schutgens, et al. · HemaSphere · 11
Evaluation and Management of Bing–Neel Syndrome
2023 · Sarah J. Schep, Josephine M.I. Vos, et al. · Hematology/Oncology Clinics of North America · 6
No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients
2023 · Sarah J. Schep, Kathelijn Fischer, et al. · Haemophilia · 3
Inhibitors and immune tolerance induction in hemophilia A: A balancing act
2022 · Schep, Sarah Judith
PDF
Works count: 9
Citation count: 234
H-index: 6
I10-index: 5
Year
Topic
Type